ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Topical ruxolitinib ± oral baricitinib in the treatment of active non-segmental vitiligo: A retrospective analysis.
Yaohua Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.